The Cancer Panel Collection, for use on the MassARRAY® System, has been designed for targeted, highly multiplexed analysis for profiling a variety of suspected cancer-derived samples including formalin-fixed tissue, fine needle aspirates, or plasma.

Ultrasensitive Panels for Liquid Biopsy

UltraSEEK™ Colon Panel

Using as little as 10 ng of input DNA, the UltraSEEK Colon Panel identifies mutations across KRAS, NRAS, EGFR, and PIK3CA genes in liquid biopsy samples, detecting mutations as low as 0.1% allele frequency.
Product Flyer, Mutation List

UltraSEEK Lung Panel 

Using as little as 10 ng of input DNA, the UltraSEEK Lung Panel identifies mutations across BRAF, EGFR, ERBB2, KRAS, and PIK3CA genes in liquid biopsy samples, detecting mutations as low as 0.1% allele frequency.
Product Flyer, Mutation List

Highly Sensitive Panels for Solid Tumor

iPLEX® HS Colon Panel 

The iPLEX HS Colon Panel identifies mutations across KRAS, NRAS, EGFR, and PIK3CA genes in solid tissue samples, detecting mutations as low as 1% allele frequency.
Product Flyer, Mutation List

iPLEX HS Lung Panel 

The iPLEX HS Lung Panel identifies mutations across BRAF, EGFR, ERBB2, KRAS, and PIK3CA genes from poor and degraded samples such as FFPE tissue, FNA, and cytology blocks, detecting mutations as low as 1% allele frequency.
Product Flyer, Mutation List

Additional Cancer Panels

OncoCarta Panel

The OncoCarta Panel includes more than 230 somatic mutations across 19 oncogenes and is ideal for orthogonal validation of NGS-based screening or targeted discovery.
Product Flyer

OncoFOCUS Panel

The OncoFOCUS Panel covers 300+ somatic mutations in 4 key oncogenes observed in lung, colorectal, and metastatic tumors including EGFR, KRAS, NRAS, and BRAF. While the panel is designed in 12 multiplexed assays, a novel upfront PCR design requires only 20 nanograms of sample.
Product FlyerMutation ListApplication Note

LungCarta® Panel

The LungCarta Panel provides a highly sensitive panel for evaluating more than 250 somatic mutations in 26 genes for targeted profiling in non-small cell lung cancer (NSCLC). Subsets of NSCLC can be further defined at the molecular level by recurrent driver mutations that occur in multiple oncogenes including AKT1, ALK, BRAF, EGFR, ERBB2, KRAS, MET, NRAS, and PIK3CA, which are included in the panel.
Product Flyer

Chemistries Overview Brochure